Effect of different doses of olmesartan medoxomil compared to losartan on proteinuria, renal function and inflammatory markers in type 2 diabetics with nephropathy

Trial Profile

Effect of different doses of olmesartan medoxomil compared to losartan on proteinuria, renal function and inflammatory markers in type 2 diabetics with nephropathy

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2008

At a glance

  • Drugs Losartan; Olmesartan medoxomil
  • Indications Diabetic nephropathies; Hypertension
  • Focus Therapeutic Use
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2004.
    • 03 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top